Pune-based healthcare artificial intelligence startup Froncort.AI has received a $2.3 million grant from Google.org to expand its AI-powered disease screening platform across India. The support also includes $200,000 in Google Cloud credits and technical assistance from Google experts.

Founded in 2024 by physician-scientist Dr Ujjwal Rao, Froncort.AI plans to use the grant to develop mAI-NETRA, a mobile version of its existing AI-NETRA platform. The application is designed to help frontline health workers identify neighbourhoods at higher risk of infectious diseases and plan targeted household screening visits.

The company is among 15 organisations selected for Google.org’s Impact Challenge: AI for Government Innovation, a global initiative backed by a $30 million funding pool. Google announced the selected organisations in September 2026 after receiving more than 2,600 proposals from around the world.

Unlike a conventional venture capital investment, the Google.org support is philanthropic funding for a public-impact project rather than a disclosed equity financing round.

Froncort.AI Plans To Expand Screening Across Six Diseases

The new mobile application will initially focus on six infectious diseases: tuberculosis (TB), leprosy, malaria, dengue, cholera and leptospirosis.

AI-NETRA combines government health programme data with Google’s Earth AI models and local environmental indicators, including settlement density, land use, rainfall and flooding. The system identifies high-risk geographical pockets within approximately 300-metre zones and converts them into ranked household clusters and routes for field workers.

The mobile version is being designed to work offline and in local languages, allowing health workers to access screening plans through their smartphones, including in areas with limited internet connectivity.

Froncort.AI says government health programme data will remain stored and processed locally in India, while Google’s models will contribute satellite-based and environmental insights.

The company plans to deploy mAI-NETRA across up to eight high-burden districts in three Indian states, with a potential coverage of two to three million people.

The rollout will be independently monitored against five performance targets. These include finding at least 20% more cases, reducing the number of people screened per confirmed case by more than 50%, improving sample transportation time, lowering government expenditure per case detected and increasing performance-based earnings for frontline health workers.

These are deployment targets, not results already achieved.

Pune TB Pilot Shows Lower Screening Requirements

The grant builds on Froncort.AI’s earlier AI-NETRA validation work with Maharashtra’s State TB Office and implementation partner FIND.

The company's published Pune pilot report, dated July 22, 2026, provides the underlying results. In the prospective field comparison, AI-guided teams screened 66,095 people and identified 10 bacteriologically confirmed, NAAT-positive pulmonary TB cases. The standard screening campaign covered 1,77,322 people and identified nine cases under the same definition.

This translated into approximately 6,610 people screened for every confirmed case in the AI-guided arm, compared with 19,702 under standard screening. The study calculated a reduction of around 66% in the number of people needing screening per confirmed case.

The report also estimated that the cost per bacteriologically confirmed case declined from ₹27.6 lakh under standard screening to ₹9.3 lakh with AI-guided targeting. Separately, 92% of participating ASHAs reported a reduction in workload.

The results suggest that geographical targeting could help public health programmes concentrate limited screening resources in neighbourhoods with higher disease risk, rather than relying entirely on broad, untargeted campaigns.

Study Limitations Remain Important

While the findings are encouraging, the pilot does not establish that AI-guided screening detects more TB cases overall.

The report states that, when all confirmed TB cases were counted rather than only NAAT-positive pulmonary cases, the AI-guided arm recorded 15 cases compared with 32 in the standard arm. The standard campaign also had access to a mobile chest X-ray van, which was not available to the AI-guided team.

Another limitation was that the comparison campaigns took place in different time periods, meaning seasonal and other changes were not controlled. The primary bacteriological result was also based on a relatively small number of confirmed cases.

The study therefore recommends a concurrent, like-for-like trial with harmonised case definitions and equal diagnostic access to establish whether the approach can consistently improve public health outcomes.

This distinction is important: the pilot provides evidence of screening efficiency, but further evaluation is needed before claiming that the technology improves overall case detection.

Open-Source Model Could Support Wider Government Adoption

Froncort.AI plans to publish mAI-NETRA as an open-source blueprint, allowing other governments to adapt the technology for their public health programmes.

For India’s healthcare system, the potential application extends beyond disease prediction. Better identification of high-risk areas could help district health authorities allocate field workers, organise diagnostic resources and plan sample transportation more efficiently.

For the startup ecosystem, the grant also highlights a different route to scaling health technology. Government partnerships, measurable public-health outcomes and technical support from large technology companies can provide an alternative to relying exclusively on commercial healthcare customers.

However, the long-term value of mAI-NETRA will depend on whether its pilot-level efficiency gains translate into reliable outcomes across different districts, disease categories and local healthcare systems.

With the Google.org grant, Froncort.AI now has an opportunity to test that proposition at a significantly larger scale. The next milestone will not simply be the number of districts covered, but whether the platform can help government health programmes find cases more efficiently while ensuring patients receive timely diagnosis and treatment.

View all
Explore
The Unicorn Magazine

The Unicorn Magazine is a business and technology media platform & Magazine, decoding the ideas, people, and companies shaping the future of India. We go beyond headlines to uncover the stories, strategies, and insights behind startups, entrepreneurs, investors, and innovators.

More